Sana Biotechnology, Inc. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

11.18 M

Shareholding (Mar 2025)

FII

13.53%

Held by 95 FIIs

DII

40.25%

Held by 48 DIIs

Promoter

15.11%

How big is Sana Biotechnology, Inc.?

22-Jun-2025

As of Jun 18, Sana Biotechnology, Inc. has a market capitalization of 633.81 million and reported net sales of 0.00 million with a net profit of -208.67 million over the latest four quarters. Shareholder's funds are 250.50 million, and total assets amount to 501.02 million.

What does Sana Biotechnology, Inc. do?

22-Jun-2025

Sana Biotechnology, Inc. is a small-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net loss of $49 million and a market cap of $633.81 million. The company has no dividend yield and negative return on equity.

Is Sana Biotechnology, Inc. technically bullish or bearish?

05-Nov-2025

As of October 31, 2025, Sana Biotechnology, Inc. has a mildly bullish technical trend, supported by bullish daily moving averages and a strong year-to-date return of 154.6%, despite underperforming the S&P 500 over the 1-year and 3-year periods.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 776 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.51

Return on Equity

-164.87%

Price to Book

6.33

Revenue and Profits:

Net Sales:

(Quarterly Results - Jun 2025)

Net Profit:

-94 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

73.24%

6 Months

121.37%

1 Year

101.56%

2 Years

28.22%

3 Years

14.35%

4 Years

-68.93%

5 Years

0.0%

Sana Biotechnology, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Is Sana Biotechnology, Inc. technically bullish or bearish?

As of 31 October 2025, the technical trend for Sana Biotechnology, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages indicate a bullish stance. Bollinger Bands are also showing a mildly bullish trend on both weekly and monthly time frames. However, the KST is mildly bearish on the weekly and mildly bullish on the monthly, and Dow Theory indicates a mildly bearish trend on the weekly with no trend on the monthly. In terms of performance, the stock has had a strong year-to-date return of 154.6%, significantly outperforming the S&P 500's 16.3%, but it has underperformed over the 1-year and 3-year periods compared to the benchmark. Overall, the current technical stance is mildly bullish, driven primarily by the bullish daily moving averages and the weekly MACD....

Is Sana Biotechnology, Inc. technically bullish or bearish?

As of 31 October 2025, the technical trend for Sana Biotechnology, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The Bollinger Bands indicate a mildly bullish stance on the weekly and a bullish stance on the monthly. Moving averages on the daily are bullish, but the KST shows a mildly bearish weekly and a mildly bullish monthly. Dow Theory supports a mildly bullish outlook in both weekly and monthly contexts, while the OBV indicates a mildly bearish trend on both time frames. In terms of returns, the company has performed well year-to-date with a return of 180.37% compared to the S&P 500's 16.30%, and over the past year, it has returned 24.86% against the S&P 500's 19.89%. However, the 3-year return is -8.6%, significantly underperforming the S&P 500's 76.66%. Overall, the current technical stance is mildly bullish, driven by the mixe...

Is Sana Biotechnology, Inc. technically bullish or bearish?

As of 31 October 2025, the technical trend for Sana Biotechnology, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The Bollinger Bands indicate a mildly bullish stance on the weekly chart and a bullish stance on the monthly chart. Daily moving averages are bullish, but the KST shows a mildly bearish signal on the weekly and mildly bullish on the monthly. Dow Theory is mildly bullish across both weekly and monthly periods. However, the OBV is mildly bearish on both time frames. In terms of performance, the stock has returned 33.78% over the past month compared to the S&P 500's 1.92%, and it has a year-to-date return of 203.68% versus the S&P 500's 16.30%. Overall, the current technical stance is mildly bullish, driven primarily by the bullish signals from moving averages and Bollinger Bands, despite some mixed indicators from KST and OBV...

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-100.00%

EBIT Growth (5y)

-390.36%

EBIT to Interest (avg)

-248.21

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.46

Sales to Capital Employed (avg)

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

75.30%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.06

EV to EBIT

-2.51

EV to EBITDA

-2.73

EV to Capital Employed

4.81

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-191.53%

ROE (Latest)

-101.79%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Mildly Bullish

Dow Theory

No Trend

Mildly Bullish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 47 Schemes (31.12%)

Foreign Institutions

Held by 95 Foreign Institutions (13.53%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -86.48% vs 55.88% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-41.20",
          "val2": "-48.80",
          "chgp": "15.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-50.90",
          "val2": "3.40",
          "chgp": "-1,597.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-93.80",
          "val2": "-50.30",
          "chgp": "-86.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 5.82% vs -5.12% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-256.00",
          "val2": "-294.90",
          "chgp": "13.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.30",
          "val2": "32.70",
          "chgp": "-103.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-266.80",
          "val2": "-283.30",
          "chgp": "5.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-41.20

-48.80

15.57%

Interest

0.00

Exceptional Items

-50.90

3.40

-1,597.06%

Consolidate Net Profit

-93.80

-50.30

-86.48%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -86.48% vs 55.88% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-256.00

-294.90

13.19%

Interest

0.00

Exceptional Items

-1.30

32.70

-103.98%

Consolidate Net Profit

-266.80

-283.30

5.82%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 5.82% vs -5.12% in Dec 2023

All Annual Results

Company CV

About Sana Biotechnology, Inc.

Sana Biotechnology, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Sana Biotechnology, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Sana Biotechnology, Inc.?

Watch in Real-Time

What does Sana Biotechnology, Inc. do?

Is Sana Biotechnology, Inc. technically bullish or bearish?

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Is Sana Biotechnology, Inc. technically bullish or bearish?

Is Sana Biotechnology, Inc. technically bullish or bearish?

Is Sana Biotechnology, Inc. technically bullish or bearish?

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Annual Results Snapshot (Consolidated) - Dec'24

About Sana Biotechnology, Inc.

Company Coordinates